Skip to main content
Publications
Arana A , Pottegard A, Kuiper J, Booth H, Reutfors J, Calingaert B , Lund LC, Crellin E, Schmitt-Egenolf M, Kaye J, Gembert K, Rothman K , Kieler H, Dedman D, Houben E, Gutierrez L , Hallas J, Perez-Gutthann S . Long-term risk of skin cancer and lymphoma in users of topical tacrolimus and pimecrolimus: final results from the extension of the cohort study Protopic Joint European Longitudinal Lymphoma and Skin Cancer Evaluation (JOELLE) . Clin Epidemiol. 2021 Dec 29;2021(13):1141-53. doi: 10.2147/CLEP.S331287
Fortuny J , von Gersdorff G, Lassalle R, Linder M, Overbeek J, Reinold J, Toft G, Timmer A, Dress J, Blin P, Droz-Perroteau C, Ehrenstein V, Franzoni C , Herings R, Kollhorst B, Moore N, Odsbu I, Perez-Gutthann S , Schink T, Rascher K, Rasouliyan L, Rothman KJ , Saigi-Morgui N , Schaller M, Smits E, Forstner M, Intravenous Iron Consortium, Benichou J, Bircher AJ, Garbe E, Rampton DS, Gutierrez L . Use of intravenous iron and risk of anaphylaxis: a multinational observational post-authorisation safety study in Europe . Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1447-57. doi: 10.1002/pds.5319
Hoffman V, Hallas J, Linder M, Margulis AV , Suehs BT, Arana A , Enger C, Horter L, Odsbu I, Olesen M, Perez-Gutthann S , Xu Y, Kristiansen NS, Appenteng K, de Vogel S, Seeger JD. Cardiovascular risk in users of mirabegron relative to users of antimuscarinic treatments for overactive bladder: findings from a non-interventional, real-world data safety study . Presented at the Virtual ICPE 2021 Conference; August 24, 2021. Previously presented at the 2020 Virtual American Heart Association’s Scientific Sessions.
Kuiper JG, Franzoni C , Ehrenstein V, Gini R, Haug U, Moore N, Droz-Perroteau C, Bolibar B, Giner-Soriano M, Hallas J, MacDonald T, Sturkenboom M, Klungel OH, Perez-Gutthann S , Herings RM. The SIGMA Consortium: a new era of collaboration to study the safety and effectiveness of medical interventions . Poster presented at the Virtual ICPE 2021 Conference; August 23, 2021.
Hoffman V , Hallas J, Linder M, Margulis AV , Suehs BT, Arana A , Phiri K, Enger C, Horter L, Odsbu I, Olesen M, Perez-Gutthann S , Xu Y, Kristiansen NS, Appenteng K, de Vogel S, Seeger JD, mirabegron PMR-PASS study group. Cardiovascular risk in users of mirabegron compared with users of antimuscarinic treatments for overactive bladder: findings from a non-interventional, multinational, cohort study . Drug Saf. 2021 Aug;44(8):899-915. doi: 10.1007/s40264-021-01095-7
Phiri K, Hallas J, Linder M, Margulis A , Suehs B, Arana A , Bahmanyar S, Hoffman V , Enger C, Horter L, Odsbu I, Olesen M, Perez-Gutthann S , Kristiansen NS, Appenteng K, de Vogel S, Seeger J. A study of cancer occurrence in users of mirabegron and antimuscarinic treatments for overactive bladder . Curr Med Res Opin. 2021 May;37(5):867-77. doi: 10.1080/03007995.2021.1891035
Arana A , Margulis AV , Varas-Lorenzo C, Bui CL , Gilsenan A , McQuay LJ, Reynolds M , Rebordosa C , Franks B, de Vogel S, Appenteng K, Perez-Gutthann S . Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom . Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):237-47. doi: 10.1002/pds.5150
Pladevall M , Pottegard A, Schink T, Reutfors J, Morros R, Poblador-Plou B, Timmer A, Forns J , Hellfritzsch M, Reinders T, Hagg D, Giner-Soriano M, Prados-Torres A, Cainzos-Achirica M, Hallas J, Kollhorst B, Brandt L, Cortes J, Aguado J , Perlemuter G, Falissard B, Castellsague J, Jacquot E, Deltour N, Perez-Gutthann S . Agomelatine and other antidepressants and the risk of acute liver injury (ALI), a post authorisation safety study (PASS) in four European countries . Poster presented at the 31st ECNP Congress; October 8, 2018. Barcelona, Spain. Previously presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Margulis AV , Linder M, Arana A , Pottegard A, Berglind IA, Bui CL , Kristiansen NS, Bahmanyar S, McQuay LJ, Atsma WJ, Appenteng K, D'Silva M, Perez-Gutthann S , Hallas J. Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom . PLoS One. 2018 Sep 27;13(9):e0204456. doi: 10.1371/journal.pone.0204456
Margulis AV , Fortuny J , Kaye JA, Calingaert B , Reynolds M , Plana E , McQuy LJ, Atsma WJ, Franks B, de Vogel S, Perez-Gutthann S , Arana A . Value of free-text comments for validating cancer cases using primary-care data in the United Kingdom . Epidemiology. 2018 Sep;29(5):e41-2.
Castellsague J, Poblador-Plou B, Giner-Soriano M, Linder M, Scholle O, Calingaert B , Bui C , Arana A , Laguna C, Gonzalez-Rubio F, Roso-Llorach A, Prados-Torres A, Perez-Gutthann S . Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany . Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):953-61. doi: 10.1002/pds.4584
Setoguchi S, Stang P, Perez-Gutthann S , May F, Klungel O, Strom B, Sahin L, Caduff P, Zhou W, Young JC, Chou Su C, Hester L, Zhu Y, Cesta C, Ahad MZ, Horton D, Hernandez-Diaz S. It takes a village part II: workshop to reconsider core competencies for new generations in the global and rapidly changing community of pharmacoepidemiology . Presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2018. Prague, Czech Republic.
Pladevall M , Hallas J, Schink T, Reutfors J, Morros R, Poblador-Plou B, Forns J , Hellfritzsch M, Reinders T, Hagg D, Giner-Soriano M, Prados-Torres A, Cainzos-Achirica M, Pottegard A, Kollhorst B, Brandt L, Cortes J, Aguado J , Perlemuter G, Castellsague J, Jacquot E, Deltour N, Perez-Gutthann S . Agomelatine and other antidepressants and the risk of acute liver injury (ALI), a PASS in four European countries . Presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 24, 2018. Prague, Czech Republic. doi: 10.1002/pds.4629
Forns J , Cainzos-Achirica M, Hellfritzsch M, Giner-Soriano M, Poblador-Plou B, Hallas J, Morros R, Prados-Torres A, Pottegard A, Cortes J, Aguado J , Castellsague J, Jacquot E, Deltour N, Perez-Gutthann S , Pladevall M . How valid are the codes used to identify acute liver injury (ALI)? A study in 3 European data sources . Presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug 17; 27(S2):371-2. doi: 10.1002/pds.4629
Tormos A , Rebordosa C , Thomas S, Plana E , Rasouliyan L, Pladevall-Vila M , Fazeli-Farsani S, Deruaz-Luyet A, Brodovicz KG, Perez-Gutthann S . Time between laboratory tests and acute liver and kidney injury diagnosis codes in CPRD: are we doing it right? Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 26, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):452. doi: 10.1002/pds.4629
Cainzos-Achirica M, Rebordosa C , Vela E, Cleries M, Matsushita K, Plana E , Rivero-Ferrer E , Enjuanes C, Jimenez-Marrero S, Garcia-Rodriguez LA, Comin-Colet J, Perez-Gutthann S . Challenges of evaluating chronic heart failure and acute heart failure events in research studies using large health care databases . Am Heart J. 2018 Aug;202:76-83. doi: 10.1016/j.ahj.2018.05.005
Cainzos-Achirica M, Varas-Lorenzo C, Pottegard A, Asmar J, Plana E , Rasmussen L, Bizouard G, Forns J , Hellfritzsch M, Zint K, Perez-Gutthann S , Pladevall-Vila M . Methodological challenges when evaluating potential off-label prescribing of drugs using electronic health care databases: a case study of dabigatran etexilate in Europe . Pharmacoepidemiol Drug Saf. 2018 Jul;27(7):713-23. doi: 10.1002/pds.4416
Arana A , Margulis AV , McQuay LJ, Ziemiecki R , Bartsch JL , Rothman KJ , Franks B, D Silva M, Appenteng K, Varas-Lorenzo C, Perez-Gutthann S . Variation in cardiovascular risk related to individual antimuscarinic drugs used to treat overactive bladder: a cohort study in the UK . Pharmacotherapy. 2018 Jun;38(6):628-37. doi: 10.1002/phar.2121.
Kuiper JG, van Herk-Sukel MPP, Castellsague J, Pottegard A, Berglind IA, Dedman D, Gutierrez L , Calingaert B , Hallas J, Sundstrom A, Gallagher AM, Kaye JA, Pardo C, Rothman KJ , Perez-Gutthann S . Use of topical tacrolimus and topical pimecrolimus in four European countries: a multicentre database cohort study . Drugs Real World Outcomes. 2018 Jun;5(2):109-16. doi: 10.1007/s40801-018-0133-1
Perez-Gutthann S . Looking behind the code . Presented at the 7th Bordeaux Pharmacoepi Festival 2018; May 23, 2018. Bordeaux, France. Previously presented at the 10th Annual Harry Guess Memorial Lecture.
Castellsague J, Kuiper JG, Pottegard A, Anveden Berglind I, Dedman D, Gutierrez L , Calingaert B , van Herk-Sukel MP, Hallas J, Sundstrom A, Gallagher AM, Kaye JA, Pardo C, Rothman KJ , Perez-Gutthann S . A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation – JOELLE study) . Clin Epidemiol. 2018 Mar 13;2018(10):299-310. doi: 10.2147/CLEP.S146442
Margulis AV , Fortuny J , Kaye JA, Calingaert B , Reynolds M , Plana E , McQuay LJ, Atsma WJ, Franks B, de Vogel S, Perez-Gutthann S , Arana A . Validation of cancer cases using primary care, cancer registry, and hospitalization data in the UK . Epidemiology. 2018 Mar;29(2):308-13. doi: 10.1097/EDE.0000000000000786
Sakamoto C, Sugano K, Ota S, Sakaki N, Takahashi S, Yoshida Y, Tsukui T, Osawa H, Sakurai Y, Yoshino J, Mizokami Y, Mine T, Arakawa T, Kuwayama H, Saigenji K, Yakabi K, Chiba T, Shimosegawa T, Sheehan JE, Perez-Gutthann S , Yamaguchi T, Kaufman DW, Sato T, Kubota K, Terano A. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan . Eur J Clin Pharmacol. 2006;62(9):765-72.